Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Scientists hail historic malaria vaccine approval — but point to challenges ahead

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout


Updates & Corrections

  • Correction 08 October 2021: An earlier version of this story incorrectly attributed the finding that the RTS,S vaccine could prevent the deaths of 23,000 children a year if a full series of doses were distributed to kids in countries with a high incidence of malaria. The correct attribution is a 2020 PLoS Medicine article.


  1. RTS,S Clinical Trials Partnership Lancet 386, 31–45 (2015).

    Article  PubMed  Google Scholar 

  2. Hogan, A. B., Winskill, P. & Ghani, A. C. PLoS Med. 17, e1003377 (2020)

    Article  PubMed  Google Scholar 

  3. Chandramohan, D. et al. N. Engl. J. Med. 385, 1005–1017 (2021).

    Article  PubMed  Google Scholar 

Download references


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links